# Probiotic applications of bifidobacteria in poultry: administration methods and microencapsulation techniques

**Authors:** Eloy Argañaraz-Martínez, María Cristina Apella, Adriana Perez Chaia, Jaime Daniel Babot

PMC · DOI: 10.20517/mrr.2025.64 · Microbiome Research Reports · 2025-08-22

## TL;DR

This review explores how Bifidobacterium can be used as a probiotic in poultry, focusing on effective delivery methods and microencapsulation to improve their survival and effectiveness.

## Contribution

The paper provides a comprehensive analysis of administration routes and microencapsulation techniques for Bifidobacterium in poultry.

## Key findings

- Bifidobacteria improve poultry gut health by modulating microbiota and immune responses.
- Microencapsulation techniques like spray drying and extrusion enhance bacterial survival in harsh conditions.
- Tailoring delivery methods and encapsulation materials is crucial for maximizing probiotic efficacy in poultry.

## Abstract

The search for sustainable alternatives to antibiotic growth promoters in poultry production has intensified in recent years, driven by global concerns over antimicrobial resistance and consumer demand for safer food systems. Among the probiotic candidates investigated, Bifidobacterium spp. stand out for their well-documented safety, immunomodulatory properties, and ability to enhance gut health. This review provides a comprehensive analysis of the biological roles, delivery strategies, and microencapsulation techniques for Bifidobacterium spp. as probiotics in poultry. Bifidobacteria contribute to poultry health by modulating the gut microbiota, improving intestinal morphology and digestive enzyme activity, and regulating immune responses through cytokine balance and epithelial barrier reinforcement. However, their strict anaerobic metabolism and sensitivity to gastric acid and processing conditions limit their viability during conventional administration. To address these challenges, we examine various administration routes, including oral, in ovo, spray/litter, and cloacal methods, highlighting their practical advantages and constraints. Special attention is given to microencapsulation technologies, such as spray drying, freeze drying, spray chilling, extrusion, and emulsion, which protect bifidobacteria from environmental stress and enhance their delivery to target intestinal sites. By integrating recent advances in biotechnology and delivery systems, this review underscores the potential of Bifidobacterium spp. as functional feed additives in antibiotic-free poultry production. Tailoring encapsulation materials and administration routes to match specific production goals is key to maximizing probiotic efficacy. Continued research on strain performance under commercial conditions will be essential to facilitate their large-scale application in sustainable poultry farming.

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 395337] {aka CHIL-6, IL-6, interleukin-6}, IL8L2 (interleukin 8 like 2) [NCBI Gene 396495] {aka CEF4, CXCL8, CXCLi2, EMF-1, EMF1, IL8}
- **Diseases:** weight gain (MESH:D015430), enteric infections (MESH:D004751), EFFECT (MESH:D065606), DSM 16284 (MESH:D001714), infections (MESH:D007239), inflammatory (MESH:D007249)
- **Chemicals:** inulin (MESH:D007444), hydrogen (MESH:D006859), acetic acid (MESH:D019342), Tween 80 (MESH:D011136), acetate (MESH:D000085), drinking water (MESH:D060766), glycolipids (MESH:D006017), vegetable oils (MESH:D010938), SCFA (MESH:D005232), trehalose (MESH:D014199), lecithin (MESH:D054709), polyethylene (MESH:D020959), nitric oxide (MESH:D009569), glucose (MESH:D005947), butyric acid (MESH:D020148), lipopeptides (MESH:D055666), water (MESH:D014867), cocoa butter (MESH:C052387), sorbitol (MESH:D013012), Lipid (MESH:D008055), sucrose (MESH:D013395), amino acids (MESH:D000596), pectin (MESH:D010368), butyrate (MESH:D002087), polysaccharides (MESH:D011134), lactate (MESH:D019344), carbohydrates (MESH:D002241), rapeseed oil (MESH:D000074262), oil (MESH:D009821), (lipo)teichoic acids (MESH:C009900), gum Arabic (MESH:D006170), starch (MESH:D013213), triglycerides (MESH:D014280), bile salts (MESH:D001647), B8101 (-), CaCO3 (MESH:D002119), hydrogen peroxide (MESH:D006861), betaine (MESH:D001622), oxygen (MESH:D010100), glycerol (MESH:D005990), alginate (MESH:D000464), carrageenan (MESH:D002351), chitosan (MESH:D048271), maltodextrin (MESH:C008315)
- **Species:** Lactococcus lactis (species) [taxon 1358], Salmonella enterica subsp. enterica serovar Pullorum (no rank) [taxon 605], Gallus gallus (bantam, species) [taxon 9031], Streptococcus salivarius (species) [taxon 1304], Enterococcus faecium (species) [taxon 1352], Lactiplantibacillus plantarum (species) [taxon 1590], Salmonella enterica subsp. enterica serovar Typhimurium (no rank) [taxon 90371], Bacillus (genus) [taxon 55087], Limosilactobacillus reuteri (species) [taxon 1598], Bacillus infantis (species) [taxon 324767], Lactobacillus acidophilus (species) [taxon 1579], Bifidobacterium adolescentis (species) [taxon 1680], Enterococcus faecalis (species) [taxon 1351], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Campylobacter lari (species) [taxon 201], Campylobacter coli (species) [taxon 195], Bifidobacterium bifidum (species) [taxon 1681], Campylobacter jejuni (species) [taxon 197], Lactococcus lactis subsp. lactis (subspecies) [taxon 1360], Bifidobacterium animalis subsp. animalis (subspecies) [taxon 302912], Pseudomonadota (proteobacteria, phylum) [taxon 1224], Ligilactobacillus salivarius (species) [taxon 1624], Leptospira sp. AB (species) [taxon 103236], Salmonella enterica subsp. enterica serovar Enteritidis (no rank) [taxon 149539], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Bifidobacterium crudilactis (species) [taxon 327277], Pediococcus acidilactici (species) [taxon 1254], Bifidobacterium bifidum ATCC 29521 = JCM 1255 = DSM 20456 (strain) [taxon 500634], Coturnix coturnix (Common quail, species) [taxon 9091], Acidipropionibacterium acidipropionici (species) [taxon 1748], Streptococcus (genus) [taxon 1301], Bifidobacterium longum (species) [taxon 216816], Faecalibacterium (genus) [taxon 216851], Bifidobacterium longum subsp. infantis (subspecies) [taxon 1682], Lacticaseibacillus casei (species) [taxon 1582], Bacillus subtilis (species) [taxon 1423], Listeria monocytogenes (species) [taxon 1639], Cereibacter sphaeroides (species) [taxon 1063], Escherichia coli (E. coli, species) [taxon 562], Coturnix japonica (Japanese quail, species) [taxon 93934]
- **Cell lines:** RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12540059/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12540059/full.md

## References

162 references — full list in the complete paper: https://tomesphere.com/paper/PMC12540059/full.md

---
Source: https://tomesphere.com/paper/PMC12540059